About 103 results

ALLMedicine™ Acneiform Eruptions Center

Research & Reviews  30 results

Demodex Folliculitis and Recent Dupilumab Administration.
Pediatrics Krakowski AC, Senft SC et. al.

Apr 22nd, 2021 - Two adolescent boys presented with acute acneiform eruptions in the setting of recent dupilumab administration. Subsequent investigation via direct scraping of pustules revealed live Demodex mite colonization of the face. These adolescent patients...

Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a singl...
The Journal of Dermatology; Park JH, Yoon D et. al.

Apr 21st, 2021 - Programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors have demonstrated their efficacy in the treatment of various malignancies. Despite their benefits, their immunomodulatory activities can cause unpredictable cutaneous adverse e...

Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induc...
The Journal of Dermatology; Tsutsui K, Kikuchi K et. al.

Mar 9th, 2021 - The most common adverse event of epidermal growth factor receptor inhibitors, used to treat colorectal, non-small cell lung, and head and neck cancers, is acneiform eruption, with a profound effect on treatment continuation. Prolonged acneiform er...

Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors...
Dermatology (Basel, Switzerland); Gisondi P, Geat D et. al.

Jan 29th, 2021 - Epidermal growth factor receptor (EGFR) inhibitors are routinely used in advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. However, their use is associated with gastrointestinal and cutaneous toxicities, including acneiform eru...

Efficacy of treatment for acneiform eruptions related to epidermal growth factor recept...
Medicine He C, Lin R et. al.

Jan 13th, 2021 - Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poo...

see more →

Drugs  3 results see all →

News  8 results

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

60 Years and Counting: A Celebration of Dermatologic Surgery

Jun 5th, 2012 - Fractionation The development of fractional photothermolysis was "a milestone in the history of laser technology and cutaneous resurfacing," according to Dr. Nazanin Saedi, a dermatologist in private practice in Chestnut Hill, Mass.

Budd-chiari Syndrome in a 25-year-old Woman with Behçet's Disease

Case Presentation A 25-year-old Afro-Brazilian woman was hospitalized in a public hospital with the following complaints: ascites, dyspnea after exercise, and the development of veins and edema in the abdominal wall and swelling in the legs. Five ...

Cutaneous Side-effects of EGFR Inhibitors and Their Management

Conclusion EGFR inhibitors are associated with a unique group of class- specific cutaneous toxicities, which include acneiform eruptions, paronychia, xerosis, hyperpigmentation, trichomegaly, and telangiectasia. As the use of EGFR inhibitors incre...

Cutaneous Side-effects of EGFR Inhibitors and Their Management

Further Cutaneous Side-effects Trichomegaly, with or without additional hypertrichosis, may develop after 2 to 5 months of continuous anti-EGFR treatment. Trichomegaly may cause visual discomfort, but can be effectively treated by trimming the eye...

see more →